miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2

Table 1 Correlations between miR-132 expression and clinicopathological characteristics in colorectal cancer patients n (%)

Characteristics	n	miR-132		P value
		Low	High
Age				0.307
< 60 yr	34	19 (55)	15 (45)
≥ 60 yr	28	12 (42)	16 (58)
Gender				0.437
Male	37	20 (54)	17 (46)
Female	25	11 (44)	14 (56)
CEA Level				0.127
0-5 ng/mL	32	13 (41)	19 (59)
> 5 ng/mL	30	18 (60)	12 (40)
CA199 Level				0.082
0-35 μ/mL	46	20 (43)	26 (57)
> 35 μ/mL	16	11 (69)	5 (31)
Tumor site				0.796
Colon	37	18 (49)	19 (51)
Rectum	25	13 (52)	12 (48)
Tumor size (cm)				0.016
≤ 5	41	16 (39)	25 (61)
> 5	21	15 (71)	6 (29)
Differentiation				0.776
Well/moderate	45	23 (51)	22 (49)
Poor	17	8 (47)	9 (53)
Distant metastasis				0.002
Yes	32	10 (31)	22 (69)
No	30	21 (70)	9 (30)
TNM stage
I/II	11	2 (18)	9 (72)	0.020
III/IV	51	29 (56)	22 (44)